Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation-Reference-Cited by-同舟云学术

Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation

Published:2016-07-12 Issue:5 Volume:31 Page:349-355
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Rovera Chiara¹,Mauri Massimo Carlo²,Bertin Elena³,Di Pace Chiara²,Paletta Silvia²,Reggiori Alessandra²,De Gaspari Ilaria Francesca¹,Cattaneo Dario⁴,Mari Daniela³,Altamura Alfredo Carlo¹

Affiliation:

1. Department of Neuroscience and Mental Health, Clinical Psychiatry; IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital; Milan Italy

2. Department of Neuroscience and Mental Health, Clinical Psychiatry, Clinical Psychopharmacology Unit; IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital; Milan Italy

3. Geriatric Unit; IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital; Milan Italy

4. Unit of Clinical Pharmacology; L. Sacco University Hospital; Milan Italy

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference35 articles.

1. Report of the task force on human rights;American Psychiatric Association. Task Force on Human Rights;Am J Psychiatry,1985

2. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study;Amsterdam;Am J Psychiatry,1997

3. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study;Andreescu;Br J Psychiatry,2007

4. Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary;Ball;Drugs Context,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic reference range for duloxetine in the treatment of depression revised: A systematic review and meta-analysis;Neuroscience Applied;2024

2. Duloxetine usage in depression;The Neuroscience of Depression;2021

3. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain: a Systematic review and meta-analysis;Osteoarthritis and Cartilage;2020-06

4. Efficacy and tolerability of duloxetine in patients with knee osteoarthritis: a meta‐analysis of randomised controlled trials;Internal Medicine Journal;2019-12

5. Duloxetine plasma level and antidepressant response;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2019-06